Efficient Microwave-Assisted Synthesis of Tetrahydroindazoles and their Oxidation to Indazoles

Abstract

N-Acetyl-styrylpyrazoles undergo Diels-Alder cyclo­addition reactions with N-methylmaleimide under solvent-free conditions to give the corresponding tetrahydroindazoles in good yields and high selectivity. On heating, these reactions do not occur or ­afford only traces of the cycloadducts. The stereochemistry of ­obtained cycloadducts was assigned by NMR. Oxidation of the ­tetrahydroindazoles with DDQ gave the expected indazoles and was accompanied by N-deacylation.

4-styrylpyrazoles - Diels-Alder cycloadditions - microwave irradiation - N-methylmaleimide - indazoles - dehydrogenation

References and Notes

1a Elguero J. Pyrazoles and their Benzo Derivatives, In Comprehensive Heterocyclic Chemistry   Vol. 5:  Potts KT. Katritzky AR. Rees CW. Pergamon Press; Oxford: 1984.  p.167-303  

1b Elguero J. Pyrazoles, In Comprehensive Heterocyclic Chemistry II   Vol. 3:  Shinkai I. Katritzky AR. Rees CW. Scriven EFV. Pergamon Press; Oxford: 1996.  p.1-75  

2 O’Neil MJ. Smith A. The 13^th Merck Index   Merck Research Laboratories Division of Merck & Co. Inc.; Whitehouse Station, New York: 2001. 

3a Bistocchi GA. De Meo G. Pedini M. Ricci A. Brouilhet H. Bucherie S. Rabaud M. Jacquignon P. Farmaco Ed. Sci.  1981,  36:  315 

3b Picciola G. Ravenna F. Carenini G. Gentili P. Riva M. Farmaco Ed. Sci.  1981,  36:  1037 

3c Mosti L. Sansebastiano L. Fossa P. Schenone P. Mattioli F. Il Farmaco  1992,  47:  357 

3d Gordon DW. Synlett  1998,  1065 

3e Schindler R. Hoefgen N. Heinecke K. Poppe H. Szelenyi I. Pharmazie  2000,  55:  857 

4a Lóránd T. Kocsis B. Emôdy L. Sohár P. Eur. J. Med. Chem.  1999,  1009 

4b Stefańska JZ. Gralewska R. Starościak BJ. Kazimierczuk Z. Pharmazie  1999,  54:  879 

5a Sun J.-H. Teleha CA. Yan J.-S. Rodgers JD. Nugiel DA. J. Org. Chem.  1997,  62:  5627 

5b Rodgers JD. Jonhson BL. Wang H. Greenberg RA. Erickson-Viitanen S. Klabe RM. Cordova BC. Rayner MM. Lam GN. Chang C.-H. Bioorg. Med. Chem. Lett.  1996,  6:  2919 

6 Keppler BK. Hartmann M. Met.-Based Drugs  1994,  1:  145 

7a Bland-Ward PA. Moore PK. Life Sci.  1995,  57:  131 

7b Mamiya T. Noda Y. Noda A. Hiramatsu M. Karasawa K. Kameyama T. Furukawa S. Yamada K. Nabeshima T. Neuropharmacology  2000,  39:  2391 

7c Schumann P. Collot V. Hommet Y. Gsell W. Dauphin F. Sopkova J. MacKenzie ET. Duval D. Boulouard M. Rault S. Bioorg. Med. Chem. Lett.  2001,  11:  1153 

8 Raman CS. Li H. Martásek P. Southan G. Masters BSS. Poulos TL. Biochemistry  2001,  40:  13448 

9 Connolly PJ. Wetter SK. Beers KN. Hamel SC. Haynes-Johnson D. Kiddoe M. Kraft P. Lai MT. Campen C. Palmer S. Phillips A. Bioorg. Med. Chem. Lett.  1997,  7:  2551 

10 Mosti L. Menozzi G. Fossa P. Schenone P. Lampa E. Parrillo C. Damico M. Rossi F. Il Farmaco  1992,  47:  567 

11a Behr LC. Fusco R. Jarboe CH. Pyrazoles, Pyrazolines, Pyrazolidines, Indazoles and Condensed Rings   Wiley RH. Interscience Publishers; New York: 1967. 

11b Baiocchi L. Corsi G. Palazzo G. Synthesis  1978,  633 

12a Medio-Simón M. Laviada MJA. Sepúlveda-Arques J. J. Chem. Soc., Perkin Trans. 1  1990,  2749 

12b Sepúlveda-Arques J. Abarca-González B. Medio-Simón M. Adv. Heterocycl. Chem.  1995,  63:  339 

13 Matsugo S. Takamizawa A. Synthesis  1983,  852 

14 Tomé AC. Cavaleiro JAS. Storr RC. Synlett  1996,  531 

15a Pinto DCGA. Silva AMS. Cavaleiro JAS. Heterocycl. Commun.  1997,  3:  433 

15b Pinto DCGA. Silva AMS. Cavaleiro JAS. Foces-Foces C. Llamas-Sainz AL. Jagerovic N. Elguero J. Tetrahedron  1999,  55:  10187 

15c Pinto DCGA. Silva AMS. Lévai A. Cavaleiro JAS. Patonay T. Elguero J. Eur. J. Org. Chem.  2000,  2593 

15d Pinto DCGA. Silva AMS. Cavaleiro JAS. J. Heterocycl. Chem.  2000,  37:  1629 

15e Lévai A. Patonay T. Silva AMS. Pinto DCGA. Cavaleiro JAS. J. Heterocycl. Chem.  2002,  39:  751 

15f Silva VLM. Silva AMS. Pinto DCGA. Cavaleiro JAS. Elguero J. Eur. J. Org. Chem.  2004,  4348 

16

Physical Data of ( E )-1-(1-Methyl-2,5-dioxo-3-pyrrol-idinyl)-5-styryl-3-(2-hydroxyphenyl)pyrazole ( 1d).
Mp 234-236 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 3.13 (s, 3 H, NCH ₃), 3.30 (dd, 1 H, J = 18.3, 9.1 Hz, 4′′′-CH ₂), 3.45 (dd, 1 H, J = 18.3, 5.2 Hz, 4′′′-CH ₂), 5.46 (dd, 1 H, J = 9.1, 5.2 Hz, 3′′′-CH), 6.90 (s, 1 H, H-4), 6.96 (ddd, 1 H, J = 7.7, 7.3, 1.2 Hz, H-5′), 7.00 (dd, 1 H, J = 8.4, 1.2 Hz, H-3′), 7.01 (d, 1 H, J = 15.8 Hz, H-α), 7.22-7.27 (m, 1 H, H-4′), 7.26 (d, 1 H, J = 15.8 Hz, H-β), 7.35-7.44 (m, 3 H, H-3′′,5′′,4′′), 7.53 (dd, 2 H, J = 8.1, 1.5 Hz, H-2′′,6′′), 7.59 (dd, 1 H, J = 7.7, 1.7 Hz, H-6′), 10.03 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 25.5 (NCH ₃), 34.8 (4′′′-CH₂), 55.6 (3′′′-CH), 100.8 (C-4), 112.6 (C-α), 115.8 (C-1′), 117.1 (C-3′), 119.5 (C-5′), 126.6 (C-6′), 126.9 (C-2′′,6′′), 128.9 (C-3′′,5′′), 129.1 (C-4′′), 129.9 (C-4′), 135.6 (C-1′′), 136.1 (C-β), 143.9 (C-5), 152.5 (C-3), 155.7 (C-2′), 173.3 (2′′′-C=O), 172.5 (5′′′-C=O). MS (EI): m/z (rel. int.) = 374 (30), 373 (100) [M^{+ •}], 372 (25), 262 (39), 261 (67), 231 (11), 202 (10), 155 (5), 128 (6), 115 (16), 91 (29), 77 (9), 65 (9).

17

Physical Data of ( E )-3-(2-Hydroxyphenyl)-1-methyl-5-styrylpyrazole ( 1b).
Mp 159-161 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 3.92 (s, 3 H, 1-CH₃), 6.81 (s, 1 H, H-4), 6.89 (ddd, 1 H, J = 7.9, 7.3, 1.1 Hz, H-5′), 6.91 (d, 1 H, J = 16.2 Hz, H-α), 7.02 (dd, 1 H, J = 8.0, 1.1 Hz, H-3′), 7.13 (d, 1 H, J = 16.2 Hz, H-β), 7.21 (ddd, 1 H, J = 8.0, 7.3, 1.6 Hz, H-4′), 7.32 (dd, 2 H, J = 7.6, 6.8 Hz, H-3′′,5′′), 7.39 (tt, 1 H, J = 7.6, 1.6 Hz, H-4′′), 7.51 (dd, 2 H, J = 6.8, 1.6 Hz, H-2′′,6′′), 7.57 (dd, 1 H, J = 7.9, 1.6 Hz, H-6′), 10.82 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 36.6 (1-CH₃), 98.9 (C-4), 113.7 (C-α), 116.5 (C-1′), 117.0 (C-3′), 119.2 (C-5′), 126.1 (C-6′), 126.7 (C-2′′,6′′), 128.6 (C-4′′), 128.8 (C-3′′,5′′), 129.0 (C-4′), 133.5 (C-β), 136.0 (C-1′′), 141.8 (C-5), 150.2 (C-3), 155.8 (C-2′). MS (EI): m/z (rel. int.) = 276 (100) [M^+• ], 275 (20), 231 (5), 202 (7), 185 (10), 144 (14), 128 (10), 115 (20), 102 (8), 91 (11), 77 (15). Anal. Calcd for C₁₈H₁₆N₂O: C, 78.24; H, 5.84; N, 10.14. Found:C, 77.84; H, 5.79; N, 10.02.

18a Pinto DCGA. Silva AMS. Almeida LMPM. Carrillo JR. Díaz-Ortiz A. de la Hoz A. Cavaleiro JAS. Synlett  2003,  1415 

18b Pinto DCGA. Silva AMS. Brito CM. Sandulache A. Carrillo JR. Prieto P. Díaz-Ortiz A. de la Hoz A. Cavaleiro JAS. Eur. J. Org. Chem.  2005,  2973 

19

Typical Experimental Procedure.
Acetyl chloride (1 mol equiv) was added to a stirred solution of (E)-3-(2-hydroxyphenyl)-5-styrylpyrazole (1a) in dry pyridine. The mixture was stirred at r.t. and under nitrogen atmosphere until complete disappearance of the starting 5-styrylpyrazole 1a. After that period the reaction mixture was poured over ice and H₂O, and acidified at pH 2 with a 10% solution of HCl. The resulting mixture was extracted with CHCl₃ and dried over anhyd Na₂SO₄. The solvent was evaporated to dryness and the residue purified by thin layer chromatography with CH₂Cl₂ as eluent giving the expected (E)-1-acetyl-3-(2-hydroxyphenyl)-5-styrylpyrazole (1c) in moderate yield (44%). Mp 124.4-126.2 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 2.77 (s, 3 H, 1-COCH ₃), 6.98 (ddd, 1 H, J = 7.7, 7.5, 1.1 Hz, H-5′), 7.06 (s, 1 H, H-4), 7.07 (dd, 1 H, J = 8.3, 1.1 Hz, H-3′), 7.22 (d, 1 H, J = 16.5 Hz, H-β), 7.30-7.43 (m, 4 H, H-4′,3′′,4′′,5′′), 7.57 (d, 2 H, J = 7.7 Hz, H-2′′,6′′), 7.63 (dd, 1 H, J = 7.7, 1.6 Hz, H-6′), 7.93 (d, 1 H, J = 16.5 Hz, H-α), 10.38 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 24.0 (1-COCH₃), 104.0 (C-4), 114.8 (C-1′), 116.4 (C-α), 117.3 (C-3′), 119.6 (C-5′), 127.2 (C-2′′,6′′), 127.4 (C-6′), 128.8 (C-3′′,5′′), 129.0 (C-4′′), 131.0 (C-4′), 135.6 (C-β), 136.0 (C-1′′), 145.8 (C-5), 153.9 (C-3), 156.5 (C-2′), 170.8 (1-COCH₃). MS (EI): m/z (rel. int.) = 304 (80) [M^+•], 262 (73) [M - C₂H₂O]⁺, 245 (5), 233 (5), 216 (4), 202 (6) [M - C₈H₆]⁺, 191 (2), 185 (21) [M - C₇H₅NO]⁺, 178 (4), 171 (100), 155 (3), 140 (4), 128 (5), 115 (23), 102 (6), 89 (5), 77 (8) [C₆H₅ ⁺], 65 (4). Anal. Calcd for C₁₉H₁₆N₂O₂: C, 74.98; H, 5.30; N, 9.20. Found: C, 75.01; H, 5.26; N, 9.05.

20 Silva AMS. Pinto DCGA. Cavaleiro JAS. Lévai A. Patonay T. Arkivoc  2004,  (vii):  106 

21

Physical Data of ( E )-1-Acetyl-4-(4-chlorostyryl)-3-(2-hydroxyphenyl)pyrazole ( 5b).
Mp 169.1-169.9 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 2.76 (s, 3 H, 1-COCH ₃), 6.94 (AB, 1 H, J = 16.1 Hz, H-β), 6.99 (dd, 1 H, J = 7.5, 6.9 Hz, H-5′), 7.04 (AB, 1 H, J = 16.1 Hz, H-α), 7.12 (dd, 1 H, J = 8.3, 1.1 Hz, H-3′), 7.33-7.36 (m, 1 H, H-4′), 7.36 (d, 2 H, J = 8.6 Hz, H-3′′5′′), 7.42 (d, 2 H, J = 8.6 Hz, H-2′′,6′′), 7.62 (dd, 1 H, J = 7.5, 1.6 Hz, H-6′), 8.47 (dd, 1 H, J = 0.7 Hz, H-5), 9.82 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 21.6 (1-COCH₃), 115.9 (C-1′), 117.4 (C-3′), 117.9 (C-α), 119.8 (C-5′), 122.9 (C-4), 126.2 (C-5), 127.8 (C-2′′,6′′), 128.9 (C-6′), 129.0 (C-3′′,5′′), 130.9 (C-4′), 131.3 (C-β), 133.9 (C-4′′), 135.0 (C-1′′), 152.4 (C-3), 156.0 (C-2′), 168.1 (1-COCH₃). MS (EI): m/z (rel. int.) = 340 (36) [M^+• , ³⁷Cl], 338 (81) [M^+• , ³⁵Cl], 298 (35), 296 (81), 281 (5), 267 (4), 260 (8), 242 (4), 231 (6), 202 (8), 185 (20), 171 (100), 149 (5), 115 (14), 102 (6), 77 (4). Anal. Calcd for C₁₉H₁₅ClN₂O₂: C, 67.36; H, 4.46; N, 8.27. Found: C, 67.48; H, 4.73; N, 8.30.

22

Physical Data of ( Z )-1-Acetyl-4-(4-chlorostyryl)-3-(2-hydroxyphenyl)pyrazole ( 6b).
Mp 141.8-143.6 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 2.72 (s, 3 H, 1-COCH ₃), 6.50 (dd, 1 H, J = 11.9, 1.1Hz, H-α), 6.75 (d, 1 H, J = 11.9 Hz, H-β), 6.95 (ddd, 1 H, J = 7.2, 7.9, 1.2 Hz, H-5′), 7.09 (dd, 1 H, J = 8.3, 1.2 Hz, H-3′), 7.17-7.23 (m, 4 H, H-2′′,3′′,5′′,6′′), 7.33 (ddd, 1 H, J = 7.2, 8.3, 1.6 Hz, H-4′), 7.87 (dd, 1 H, J = 7.9, 1.6 Hz, H-6′), 8.00 (d, 1 H, J = 1.1 Hz, H-5), 10.23 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 21.6 (1-COCH₃), 115.7 (C-1′), 117.3 (C-3′), 119.6 (C-5′), 119.9 (C-α), 120.0 (C-4), 127.6 (C-5), 128.5 (C-6′), 128.7 (C-2′′,6′′), 129.8 (C-3′′,5′′), 131.0 (C-4′), 132.4 (C-β), 133.5 (C-4′′), 134.4 (C-1′′), 153.1 (C-3), 156.3 (C-2′), 167.8 (C=O). MS (EI): m/z (rel. int.) = 340 (31) [M^+• , ³⁷Cl], 338 (69) [M^+• , ³⁵Cl], 298 (32), 296 (71), 281 (5), 260 (8), 231 (7), 202 (8), 185 (22), 171 (100), 149 (6), 115 (17), 102 (8), 89 (5), 77 (7). Anal. Calcd for C₁₉H₁₅ClN₂O₂: C, 67.36; H, 4.46; N, 8.27. Found: C, 67.15; H, 4.37; N, 7.98.

23

Optimised Experimental Procedure.
A mixture of (E or Z)-1-acetyl-3-(2-hydroxyphenyl)-4-styrylpyrazoles 5a-d or 6a-c and N-methylmaleimide (1:6 mole ratio) was irradiated at atmospheric pressure in an Ethos SYNTH microwave (Milestone Inc.), at 800 W for 40 min. The crude product was dissolved in CHCl₃ and purified by thin layer chromatography with a 8:2 mixture of CHCl₃-EtOAc as eluent. The residue was crystallised from EtOH to give the expected 1-acetyl-3-(2-hydroxyphenyl)-7-methyl-5-phenyl-6,8-dioxopyrrolo[3,4-g]-5,5a,8a,8b-tetrahydro-indazoles (7a, 88%; 7b, 68%; 7c, 95%; 7d, 95%; 8a, 32%; 8b, 54%; 8c, 54%).

24

Physical Data of 1-Acetyl-5-(4-ethoxyphenyl)-3-(2-hydroxyphenyl)-7-methyl-6,8-dioxopyrrolo[3,4- g ]-5,5a,8a,8b-tetrahydroindazole ( 7c).
Mp 236-237 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 1.44 (t, 3 H, J = 7.0 Hz, 4′′-OCH₂CH ₃), 2.54 (s, 3 H, 1-COCH ₃), 2.76 (s, 3 H, 7-CH ₃), 3.37 (dd, 1 H, J = 8.5, 7.4 Hz, H-5a), 3.54 (br dd, 1 H, J = 7.4, 4.5 Hz, H-5), 4.07 (dq, 2 H, J = 7.0, 1.9 Hz, 4′′-OCH ₂CH₃), 4.46 (dd, 1 H, J = 8.5, 7.1 Hz, H-8a), 4.97 (br dd, 1 H, J = 7.1, 3.6 Hz, H-8b), 6.94 (dd, 1 H, J = 4.5, 3.6 Hz, H-4), 6.96 (d, 2 H, J = 8.6 Hz, H-3′′,5′′), 6.97 (ddd, 1 H, J = 8.6, 7.2, 0.9 Hz, H-5′), 7.10 (dd, 1 H, J = 8.0, 0.9 Hz, H-3′), 7.21 (d, 2 H, J = 8.6 Hz, H-2′′,6′′), 7.38 (ddd, 1 H, J = 8.0, 7.2, 1.4 Hz, H-4′), 7.66 (dd, 1 H, J = 8.6, 1.4 Hz, H-6′), 9.85 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 14.9 (4′′-OCH₂ CH₃), 21.5 (1-COCH₃), 25.0 (7-CH₃), 40.6 (C-8a), 42.1 (C-5a), 44.5 (C-5), 57.5 (C-8b), 63.5 (4′′-OCH₂CH₃), 114.4 (C-1′), 114.5 (C-3′′,5′′), 117.7 (C-3′), 119.7 (C-5′), 126.2 (C-4), 127.5 (C-6′;), 129.0 (C-1′′), 129.8 (C-2′′,6′′), 131.9 (C-4′), 137.8 (C-3a), 149.3 (C-3), 157.1 (C-2′), 158.5 (C-4′′), 168.6 (1-COCH₃), 173.4 (C-6), 174.5 (C-8). MS (EI): m/z (rel. int.) = 459 (52) [M^+• ], 417 (28), 348 (100), 306 (70), 277 (18), 257 (10), 171 (35), 160 (7), 91 (10). Anal. Calcd for C₂₉H₂₅N₃O₅: C, 67.96; H, 5.48; N, 9.14. Found: C, 67.80; H, 5.49; N, 8.76.

25

Physical Data of 1-Acetyl-5-(4-ethoxyphenyl)-3-(2-hydroxyphenyl)-7-methyl-6,8-dioxopyrrolo[3,4- g ]-5,5a,8a,8b-tetrahydroindazole ( 8c).
Mp 244-245 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 1.42 (t, 3 H, J = 7.0 Hz, 4′′-OCH₂CH ₃), 2.46 (s, 3 H, 1-COCH ₃), 2.89 (s, 3 H, 7-CH ₃), 3.56 (br d, 1 H, J = 8.6 Hz, H-5a), 4.70 (br d, 1 H, J = 7.6 Hz, H-5), 4.02 (dq, 2 H, J = 7.0 Hz, 4′′-OCH ₂CH₃), 4.42 (dd, 1 H, J = 8.6, 8.0 Hz, H-8a), 4.80 (dd, 1 H, J = 8.0, 3.8 Hz, H-8b), 6.96 (dd, 1 H, J = 7.6, 3.8 Hz, H-4), 6.88 (d, 2 H, J = 8.7 Hz, H-3′′,5′′), 6.98 (ddd, 1 H, J = 7.6, 7.4, 1.0 Hz, H-5′), 7.09 (dd, 1 H, J = 8.2, 1.0 Hz, H-3′), 7.23 (d, 2 H, J = 8.7 Hz, H-2′′,6′′), 7.37 (ddd, 1 H, J = 8.2, 7.4, 1.5 Hz, H-4′), 7.70 (dd, 1 H, J = 7.6, 1.5 Hz, H-6′), 9.81 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 14.8 (4′′-OCH₂ CH₃), 21.5 (1-COCH₃), 25.3 (7-CH₃), 41.5 (C-8a), 41.8 (C-5), 43.0 (C-5a), 55.7 (C-8b), 63.6 (4′′-OCH₂CH₃), 114.3 (C-1′), 115.2 (C-3′′,5′′), 117.6 (C-3′), 119.7 (C-5′), 125.9 (C-4), 127.6 (C-6′), 127.9 (C-2′′,6′′), 128.2 (C-1′′), 131.8 (C-4′), 138.2 (C-3a), 149.6 (C-3), 157.0 (C-2′), 158.3 (C-4′′), 168.4 (1-COCH₃), 173.9 (C-6), 177.7 (C-8). MS (EI): m/z (rel. int.) = 459 (46) [M^+• ], 417 (29), 348 (14), 306 (42), 295 (100), 282 (14), 210 (21), 171 (36), 135 (16), 77 (5). Anal. Calcd for C₂₉H₂₅N₃O₅: C, 67.96; H, 5.48; N, 9.14. Found: C, 67.91; H, 5.45; N, 9.16.

26

Optimised Experimental Procedure.
A mixture of each of the appropriate 1-acetyl-3-(2-hydroxyphenyl)-7-methyl-5-phenyl-6,8-dioxopyrrolo[3,4-g]-5,5a,8a,8b-tetrahydroindazoles 7a,b,d or 8c and DDQ (1:3 mol ratio) in 1,2,4-trichlorobenzene was irradiated at atmospheric pressure in an Ethos SYNTH microwave (Milestone Inc.), at 800 W for 30 min. The crude product was purified by column chromatography, using light PE as eluent, to remove the 1,2,4-trichlorobenzene, followed by EtOAc to remove the reaction product, which was further purified by TLC with a 9:1 mixture of CHCl₃-EtOAc as eluent. The residue was recrystallised from EtOH to give 5-aryl-3-(2-hydroxyphenyl)-7-methyl-6,8-dioxopyrrolo[3,4-g]indazoles (9a from 7a, 85%; 9b from 7b, 32%; 9c from 8c, 31%; 9d from 7d, 34%).

27

Physical Data of 3-(2-Hydroxyphenyl)-7-methyl-5-phenyl-6,8-dioxopyrrolo[3,4- g ]indazole ( 9a).
Mp >275 °C. ¹H NMR (300.13 MHz, CDCl₃): δ = 3.21 (s, 3 H, NCH ₃), 7.05 (ddd, 1 H, J = 7.7, 7.6, 1.2 Hz, H-5′), 7.16 (dd, 1 H, J = 8.1, 1.2 Hz, H-3′), 7.36 (ddd, 1 H, J = 7.6, 8.1, 1.6 Hz, H-4′), 7.48-7.61 (m, 4 H, H-2′′,3′′,5′′,6′′), 8.02 (dd, 1 H, J = 7.7, 1.6 Hz, H-6′), 8.44 (s, 1 H, H-4), 10.47 (s, 1 H, NH), 11.27 (s, 1 H, 2′-OH). ¹³C NMR (75.47 MHz, CDCl₃): δ = 24.0 (NCH₃), 116.2 (C-1′), 117.7 (C-3′), 119.8 (C-5′), 130.2 (C-4), 127.3 (C-6′), 128.2 (C-2′′,6′′), 129.7 (C-3′′,5′′), 130.5 (C-4′), 128.5 (C-4′′), 133.1 (C-8b), 136.6 (C-5,1′′), 145.7 (C-3), 156.3 (C-2′), 133.4 (C-3a), 128.2 (C-5a), 116.5 (C-8a), 167.9 (C-6,8). MS (EI): m/z (rel. int.) = 369 (100) [M^+• ], 326 (3), 311 (3), 284 (5), 255 (5), 226 (4), 164 (3), 91 (2).

28 Lévai A. Silva AMS. Pinto DCGA. Cavaleiro JAS. Alkorta I. Elguero J. Jekö J. Eur. J. Org. Chem.  2004,  4672